anonymous
Guest
anonymous
Guest
Cant wait to see all the District Managers termed. Oh yea, their egos let them call themselves a Regional Director. HA!! What a joke. They "manage" a tiny district.
It's going to be epic. Afterward, we can post daily on another company's board that didn't hire us. Amgen and Syneos, we're coming for you!Cant wait to see all the District Managers termed. Oh yea, their egos let them call themselves a Regional Director. HA!! What a joke. They "manage" a tiny district.
Tough day on Wall Street, with a lot of high tech companies really getting slammed. The floor is in, stock is a screaming buy as is, but overall market correction is overdue.Doesn't matter who they brought in or fired they all sucked. Look at stock performance today. Down 4.7% at 13.58. This is so poor and pathetic it should be removed from the exchange and put on penny stock board.
Tough day on Wall Street, with a lot of high tech companies really getting slammed. The floor is in, stock is a screaming buy as is, but overall market correction is overdue.
Financial analyst here. Agree with above post! Any sign of CVOT data being positive and the price point of $13 will be laughable.
Buyout? Quite possibly. Remember those being bought out have a sharp rise in there stock price.
Tough day on Wall Street, with a lot of high tech companies really getting slammed. The floor is in, stock is a screaming buy as is, but overall market correction is overdue.
Financial analyst here. Agree with above post! Any sign of CVOT data being positive and the price point of $13 will be laughable.
Buyout? Quite possibly. Remember those being bought out have a sharp rise in there stock price.
There is a bit of an undercurrent in the rumor mill that the company will be bought out by a large Pharma company in the near future. The rationale being that this large company is soon to launch the cardiovascular product in the next 18 to 24 months, and they want to establish a footprint in cardiology in advance. This may not bode well for the Experion reps as large pharma will want to hand pick their own team. On the other hand, investors may be rewarded richly with the buyout.Financial analyst here. Agree with above post! Any sign of CVOT data being positive and the price point of $13 will be laughable.
Buyout? Quite possibly. Remember those being bought out have a sharp rise in there stock price.
Good call, dumb ass.Investors usually win in buyouts. The reps at Esperion are to dumb to realize their
Good call, dumb ass.
Investors usually win in buyouts. The reps at Esperion are to dumb to realize their expendable. Do we really think any of this bunch would be looked upon as valuable to retain? As soon as they babble about being a Scientfic Hire they will be cut loose quick. No way do reos or managers survive a buyout.
On purpose?What's funny is the spelling and grammar errors on purpose to drive the Scientific Hires crazy. Lol. This board is the funniest on cafepharma. Reading back on the posts for the last year has been hilarious! This company should be ashamed of themselves.